Main Article Content

Severe Acute Respiratory Syndrome-Coronavirus-2 Infection [Sars-Cov-2 (Covid-19)]: A Review


D.M Bolarin

Abstract

The outbreak of the new coronavirus disease-2019 (COVID-19) in December 2019 in China spread worldwide or globally developing into an emergency of primary international concern. SARS-CoV-2 infection leads to groups of severe respiratory disease similar to severe acute respiratory syndrome coronavirus. Human-to-human transmission through droplets, contaminated hands or surfaces has been described, with incubation times of 2 to 14 days. Early diagnosis, quarantine, and supportive treatments are essential to cure patients. This paper reviews the literature on all accessible information about the epidemiology, currently applied laboratory diagnosis, as well as therapeutical management and vaccines to prevent, treat and control further outbreaks of SARS-CoV-2 infection.


Keywords: COVID-19, Diagnosis, SARS-CoV-2, Therapeutic management, Vaccines


Journal Identifiers


eISSN: 0189-0964